EP1027049A4 - Intranasal formulation containing scopolamine and method of treating motion sickness - Google Patents
Intranasal formulation containing scopolamine and method of treating motion sicknessInfo
- Publication number
- EP1027049A4 EP1027049A4 EP98946945A EP98946945A EP1027049A4 EP 1027049 A4 EP1027049 A4 EP 1027049A4 EP 98946945 A EP98946945 A EP 98946945A EP 98946945 A EP98946945 A EP 98946945A EP 1027049 A4 EP1027049 A4 EP 1027049A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- formulation containing
- motion sickness
- intranasal formulation
- treating motion
- containing scopolamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5865197P | 1997-09-11 | 1997-09-11 | |
US58651P | 1997-09-11 | ||
PCT/US1998/018953 WO1999012544A1 (en) | 1997-09-11 | 1998-09-11 | Intranasal formulation containing scopolamine and method of treating motion sickness |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1027049A1 EP1027049A1 (en) | 2000-08-16 |
EP1027049A4 true EP1027049A4 (en) | 2001-09-05 |
Family
ID=22018094
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP98946945A Ceased EP1027049A4 (en) | 1997-09-11 | 1998-09-11 | Intranasal formulation containing scopolamine and method of treating motion sickness |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1027049A4 (en) |
JP (1) | JP2002516815A (en) |
AU (1) | AU742878B2 (en) |
CA (1) | CA2303132C (en) |
WO (1) | WO1999012544A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6572849B2 (en) * | 2000-09-20 | 2003-06-03 | Lee Shahinian, Jr. | Self-preserved antibacterial nasal, inhalable, and topical ophthalmic preparations and medications |
JP5391691B2 (en) | 2006-03-31 | 2014-01-15 | 和光純薬工業株式会社 | Pyrazole cyanine dye |
JP5476989B2 (en) | 2007-01-31 | 2014-04-23 | 和光純薬工業株式会社 | Method for detecting amplification or deletion of genomic DNA fragment |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0131315A2 (en) * | 1983-05-13 | 1985-01-16 | ISTITUTO DE ANGELI S.p.A. | Nasal preparations comprising anticholinergic quaternary ammonium salts |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7765615B2 (en) * | 2007-03-28 | 2010-08-03 | Michael Robert Eastwood | Chest protector in sports medicine |
-
1998
- 1998-09-11 CA CA002303132A patent/CA2303132C/en not_active Expired - Fee Related
- 1998-09-11 WO PCT/US1998/018953 patent/WO1999012544A1/en not_active Application Discontinuation
- 1998-09-11 AU AU93850/98A patent/AU742878B2/en not_active Ceased
- 1998-09-11 EP EP98946945A patent/EP1027049A4/en not_active Ceased
- 1998-09-11 JP JP2000510441A patent/JP2002516815A/en not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0131315A2 (en) * | 1983-05-13 | 1985-01-16 | ISTITUTO DE ANGELI S.p.A. | Nasal preparations comprising anticholinergic quaternary ammonium salts |
Non-Patent Citations (2)
Title |
---|
PUTCHA LAKSHIMI ET AL: "Bioavailability of intranasal scopolamine in normal subjects.", JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 85, no. 8, 1996, pages 899 - 902, XP002171369, ISSN: 0022-3549 * |
See also references of WO9912544A1 * |
Also Published As
Publication number | Publication date |
---|---|
CA2303132A1 (en) | 1999-03-18 |
AU742878B2 (en) | 2002-01-17 |
CA2303132C (en) | 2002-07-09 |
EP1027049A1 (en) | 2000-08-16 |
AU9385098A (en) | 1999-03-29 |
WO1999012544A1 (en) | 1999-03-18 |
JP2002516815A (en) | 2002-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP2000001783A0 (en) | Disinfectant and method of making | |
GB2334444B (en) | Hair treatment composition and method of manufacturing the composition | |
PL334678A1 (en) | Quinolinic and quinazolinic compounds useful in therapy in particular in that of bph | |
PL337999A1 (en) | Hair direct dyeing compositions containing novel mixtures of antraquinones and method of dyeing human hair | |
GB9715508D0 (en) | Industrial fabrics and method of treatment | |
US5656608B1 (en) | Amino acid compositions and methods of treatment using same | |
HUP0002213A3 (en) | Aid and method for treatment of hair especially for waving | |
ZA9610901B (en) | Treatment and prophylaxis of osteoporosis | |
GB2332647B (en) | Ferroelectric imaging member and methods of use | |
EP0975654A4 (en) | Composition and method for treatment of cmv infections | |
ZA964562B (en) | Antipsychotic agents compositions and method of use | |
EP1027049A4 (en) | Intranasal formulation containing scopolamine and method of treating motion sickness | |
EP1009433A4 (en) | Therapeutic composition and method of treatment | |
HUP0002981A3 (en) | Abrasive cleaning composition and method of cleaning | |
PL303822A1 (en) | Therapeutic compositions containing ipsapyrone and method of obtaining them | |
IL112257A0 (en) | Treatment of motion sickness | |
CZ362797A3 (en) | Process of treating binding agents and use thereof | |
EP1015559A4 (en) | Human regeneration-associated serpin-1 (rasp-1) and methods of use | |
EP0963968A4 (en) | Agent and method for surface treatment of calcium-base inorganic members | |
ZA969563B (en) | Cleaning concentrates and method of preparation | |
GB2326704B (en) | Processing apparatus and method of use | |
GB9707163D0 (en) | Cleaning composition and method of use | |
GB9706608D0 (en) | Decontamination and treatment of metal surfaces | |
IL109504A0 (en) | Scalp treatment composition and cosmetic treatment for scalp | |
PL318892A1 (en) | Disinfecting agent and method of obtaining same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20000329 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20010724 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
17Q | First examination report despatched |
Effective date: 20020103 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: NASTECH PHARMACEUTICAL COMPANY, INC. |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 20051102 |